Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of 0.05% clobetasone butyrate cream in eczema
2015-004899-30Phase 3
- Sponsor
- GSK
- Start
- Dec 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in atopic dermatitis (AD) comparing 0.05% clobetasone butyrate cream with Placebo cream base (2 arms). Primary endpoints: Change from baseline in EASI score at Day 7 and Change from baseline in EASI score at Day 14.
02
Drugs
clobetasone
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2015-004899-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004899-30.